Literature DB >> 21207334

Uterus transplantation: on the edge.

Giuseppe Del Priore1, Stefan Schlatt, Robert Wagner, Elena Reynoso, Jeanetta Malanowska-Stega.   

Abstract

Uterus transplantation for absolute uterus factor infertility is moving closer to human trials. The indication for uterus transplantation is evident as is its potential to ameliorate the social and personal burdens of these patients. The extensive collaborative research efforts between animal works, advancements in transplantation medicine, and immune suppression have culminated in demonstrating its apparent feasibility. As for the concerns regarding its risk, in perspective it is similar to other high-risk pregnancies. Moving uterus transplantation toward clinical applications obviously will require a continued commitment of research and support.

Entities:  

Mesh:

Year:  2011        PMID: 21207334     DOI: 10.1055/s-0030-1268704

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  4 in total

1.  A tissue-engineered human endometrial stroma that responds to cues for secretory differentiation, decidualization, and menstruation.

Authors:  Stacey C Schutte; Robert N Taylor
Journal:  Fertil Steril       Date:  2012-02-10       Impact factor: 7.329

2.  Use of cyclosporine in uterine transplantation.

Authors:  Srdjan Saso; Karl Logan; Yazan Abdallah; Louay S Louis; Sadaf Ghaem-Maghami; J Richard Smith; Giuseppe Del Priore
Journal:  J Transplant       Date:  2011-11-10

Review 3.  Uterus transplantation: Toward clinical application in Japan.

Authors:  Nobuhiko Suganuma; Ayako Hayashi; Iori Kisu; Kouji Banno; Hisako Hara; Makoto Mihara
Journal:  Reprod Med Biol       Date:  2017-08-06

4.  Modified uterine allotransplantation and immunosuppression procedure in the sheep model.

Authors:  Li Wei; Tao Xue; Hong Yang; Guang-Yue Zhao; Geng Zhang; Zhi-Hong Lu; Yan-Hong Huang; Xiang-Dong Ma; Hai-Xia Liu; Sheng-Ru Liang; Fang Yang; Bi-Liang Chen
Journal:  PLoS One       Date:  2013-11-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.